Literature DB >> 14044038

SYNERGISM BETWEEN SULPHONAMIDE DRUGS AND ANTIBIOTICS OF THE POLYMYXIN GROUP AGAINST PROTEUS SP. IN VITRO.

F E RUSSELL.   

Abstract

Interesting synergism in vitro between a recently introduced antibiotic, colistin methane sulphonate, and sulphonamide drugs is described. The observations were extended to polymyxin B sulphate and sulphonamides with essentially similar results. The combinations are bactericidal at therapeutic levels, the ratio of drugs to one another is not critical, and the effect is present over a fairly wide pH range.

Entities:  

Keywords:  COLISTIN; EXPERIMENTAL LAB STUDY; POLYMYXIN; PROTEUS; SULFONAMIDES

Mesh:

Substances:

Year:  1963        PMID: 14044038      PMCID: PMC480577          DOI: 10.1136/jcp.16.4.362

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  "Colomycin". Laboratory and clinical investigations.

Authors:  G TAYLOR; H ALLISON
Journal:  Br Med J       Date:  1962-07-21

2.  Pseudomonas pyocyanea infection treated with colistin methane sulphonate.

Authors:  M MCMILLAN; T M PRICE; D M MACLAREN; G W SCOTT
Journal:  Lancet       Date:  1962-10-13       Impact factor: 79.321

3.  The use of colymycin in chronic urinary infections due to Pseudomonas aeuroginosa.

Authors:  G CARROLL; W F MALETTE
Journal:  J Urol       Date:  1961-01       Impact factor: 7.450

  4 in total
  12 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  In vitro additive effect of polymxin B and rifampin against Serratia marcesen.

Authors:  W H Traub; I Kleber
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

3.  Inducible high resistance to colistin in Proteus strains.

Authors:  S Shimizu; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

4.  Synergism of polymyxin and sulfonamides in L-forms of Staphylococcus aureus and Proteus mirabilis.

Authors:  J Z Montgomerie; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

5.  Colistin, sulphamethoxazole, and trimethoprim in synergy against Gram-negative bacteria.

Authors:  N A Simmons
Journal:  J Clin Pathol       Date:  1970-12       Impact factor: 3.411

6.  Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections.

Authors:  F E Thomas; J M Leonard; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

7.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

8.  [Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline].

Authors:  F D Daschner
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Gram-negative bacterial endocarditis in narcotic addicts.

Authors:  J E Rosenblatt; J G Dahlgren; R S Fishbach; F P Tally
Journal:  Calif Med       Date:  1973-02

10.  Potentiation of inhibitory activity of colistin on Pseudomonas aeruginosa by sulphamethoxazole and sulphamethizole.

Authors:  N A Simmons
Journal:  Br Med J       Date:  1969-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.